×

UPSC Courses

DNA banner

DAILY NEWS ANALYSIS

GS-III :
  • 05 August, 2020

  • 3 Min Read

Covishield: 2nd – 3rd Phase trails

Covishield: 2nd – 3rd Phase trails

Recently, the Drugs Controller General of India (DCGI) has given approval to the Serum Institute of India (SII), Pune to conduct Phase II/III clinical trials of Covishield in India. SII is the world’s largest maker of vaccines and it has a tie-up with AstraZeneca, the Swedish-British pharma giant, to manufacture the Covid-19 vaccine for low- and middle-income countries.

  • Covishield:
    It is the name given to an Oxford-AstraZeneca Covid-19 vaccine candidate which is technically referred to as AZD1222 or ChAdOx 1 nCoV-19.
  • It is already being tested in the UK, South Africa and Brazil, where participants are being administered two doses nearly a month apart.
  • It had triggered an immune response in humans against the novel coronavirus in early trials and is considered to be one of the global frontrunners for the Covid-19 vaccine.

Background: The Subject Expert Committee (SEC) for Covid-19 related therapies of the Central Drugs Standard Control Organisation (CDSCO) felt that the SII needed to take a ‘pan India’ approach while considering trial sites.

  • It recommended that authorisation to market Covishield should be granted after considering clinical data generated from both the India and international trials.
  • Trials: SII can now start its larger phase II/III trials, ahead of other vaccine candidates like Bharat Biotech’s Covaxin and Zydus Cadila’s ZyCov-D which are still in phase I/II trials.
  • However, the exact timings of trial beginning are not clear yet. It would take at least a week to get the ethics committee’s approval before starting the trials. If everything goes well, the vaccine could be out by the end of 2020.
  • The trials for Covishield will have around 1,600 participants at 18-odd sites across the country including those identified by the National Biopharma Mission and Grand Challenges India Programme.

Current Trend in India: India continues to improve the Case Fatality Rate (CFR-number of deaths per positive case) and maintain its global position of having one of the lowest Covid-19 fatalities rates. The current CFR is 2.11%.

Grand Challenges India Programm

  • It is a partnership framework for the Department of Biotechnology (DBT) in India, its Biotechnology Industry Research Assistance Council (BIRAC) and the Bill and Melinda Gates Foundation. BIRAC is a Public Sector Enterprise, set up by the DBT.
  • Aim: To launch joint initiatives aimed at catalyzing innovative health and development research within India.

National Biopharma Mission

  • It is an industry-academia collaborative mission for accelerating biopharmaceutical development in the country.
  • It was launched in 2017 at a total cost of Rs. 1500 crore and is 50% co-funded by World Bank loan.
  • It is being implemented by the BIRAC.

Source: TH


National Investment and Manufacturing Zones (NIMZ)

About National Investment and Manufacturing Zones (NIMZ) The Government of India (GoI) has announced a National Manufacturing Policy, 2011, with the objective of enhancing the share of manufacturing in GDP to 25% within a decade and creating 100 million jobs. NIMZs are one of the important instruments to achieve it. As per the Policy, &ldqu

International Financial Services Center (IFSC)

What is an International Financial Services Center (IFSC)? An IFSC caters to customers outside the jurisdiction of the domestic economy.  Such centres deal with flows of finance, financial products and services across borders.  London, New York and Singapore can be counted as global financial centres.  The&n

4G Vs. 5G

4G Vs. 5G Context: This topic is important for UPSE GS Paper 3 And Prelims. Background- "G" stands for "GENERATION". While connected to the internet, the speed of the connection depends upon the signal strength that is shown in abbreviations like 2G, 3G, 4G, 5G, etc. on any mobile device. Each generation of wir

 India-U.S. Relations Overview

 India-U.S. Relations Overview Context: This topic is important for UPSE GS Paper2.  India-U.S. bilateral relations have developed into a "global strategic partnership", based on shared democratic values and increasing convergence of interests on bilateral, regional and global issues. The cooperation is based on th

G-20 analysis

G-20 analysis Context: This topic is important for UPSE GS Paper 2. The G20 summit in Rome, agreed to end international public finance for new coal power generation abroad by 2021-end and mobilise funds to support low emission power development to achieve ‘climate goals’ .Let’s understand G20 in detail. About the G20

Students Achievement

Search By Date

Newsletter Subscription
SMS Alerts